Latest Regulatory News

NSX Limited reported a net cash outflow from operations of AUD 1.3 million in Q3 2025 but is bolstering its liquidity through a new capital raising initiative to sustain ongoing activities.

Oakridge International Limited reported strong operational and financial progress for Q1 2025, highlighting increased trading income, positive cash flow, and a robust sales pipeline in healthcare IoT technology despite ongoing legal discussions.

CAQ Holdings Limited posted a 5% decline in leasing revenue for the March 2025 quarter, while vacancy rates held steady and operating cash flow remained positive despite ongoing regulatory uncertainties in China.

Zenith Minerals reported a pivotal quarter advancing exploration at its Dulcie Far North and Red Mountain gold projects, while agreeing to divest its Turkish Kavaklitepe interest, sharpening its focus on domestic assets.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

Reedy Lagoon Corporation has completed an extensive FineFraction soil sampling program across four gold prospects at Burracoppin, while seeking a farm-in partner for its iron project and maintaining a cautious cash position.

Atlantic Lithium has secured all essential permits for its flagship Ewoyaa Lithium Project in Ghana and updated its feldspar resource estimate, while navigating funding challenges and awaiting parliamentary ratification of its mining lease.

Peppermint Innovation Ltd reports a transformative quarter marked by explosive user growth on its Pinoy Coop Mobile platform, record loan approvals via bizmoLoan, and key partnerships with major Philippine financial institutions.

Black Rock Mining advances its Mahenge Graphite Project with a A$5 million placement and POSCO’s strategic US$277 million investment in a Korean spherical graphite plant, signaling strengthened downstream integration and project momentum.

Clarity Pharmaceuticals reports a robust cash position and strategic refocus on its lead prostate cancer asset, Cu-SAR-bisPSMA, supported by multiple FDA Fast Track designations and advancing clinical trials.

SomnoMed Limited reported a robust 23.2% revenue increase in Q3 FY25, reaffirming its full-year guidance while actively addressing new US tariffs through potential duty-free exemptions.

Lunnon Metals Limited has showcased significant progress in its gold and nickel exploration projects, highlighting strong drilling results and development plans for the Lady Herial gold deposit and Baker-Foster nickel resources.